home / stock / scni / scni news

SCNI News and Press, Scanner Technologies Corp From 11/07/23

Stock Information
Company Name: Scanner Technologies Corp
Stock Symbol: SCNI
Market: OTC
Website: biondvax.com
Menu
SCNI SCNI Quote SCNI Short SCNI News SCNI Articles SCNI Message Board
Get SCNI Alerts

News, Short Squeeze, Breakout and More Instantly...
SCNI - InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receive $900K IIA Grant for New CDMO Business Unit

Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, has been nam...
SCNI - Scinai Immunotherapeutics receives non-compliance letter from Nasdaq

2023-11-06 12:22:00 ET More on Scinai Immunotherapeutics Seeking Alpha’s Quant Rating on Scinai Immunotherapeutics Historical earnings data for Scinai Immunotherapeutics Financial information for Scinai Immunotherapeutics For further details see: S...

SCNI - InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Status Report on NASDAQ Compliance

Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, has received...

SCNI - Scinai Immunotherapeutics Provides Update Regarding Nasdaq Compliance

JERUSALEM, Nov. 03, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment o...
SCNI - Potential Complications of Untreated Psoriasis

Psoriasis is a skin condition that causes individuals to develop a rash with scaly, itchy patches on their elbows, knees, trunk and scalp. This chronic illness, which may start off as a few itchy patches, can severely affect an individual’s quality of life. Psoriasis is often accompanie...

SCNI - Expected earnings - Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd. (SCNI) is expected to report for Q3 2023

SCNI - Scinai Immunotherapeutics GAAP EPS of $0.002

2023-11-01 03:07:45 ET More on Scinai Immunotherapeutics Seeking Alpha’s Quant Rating on Scinai Immunotherapeutics Historical earnings data for Scinai Immunotherapeutics Financial information for Scinai Immunotherapeutics For further details see: S...
SCNI - InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Q3 2023 Financial Report, Reports Possible Adjustment of Facility Terms by EIB

Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, is repo...

SCNI - European Investment Bank (EIB) considering extending maturity of its financial facility contract with Scinai Immunotherapeutics in light of Scinai's recent strategic pivot

Recently rebranded Scinai Immunotherapeutics shifted drug development focus from COVID-19 antibody to a novel antibody for the treatment of psoriasis and launched a CDMO business unit Adjusted terms being considered by EIB would extend maturity of finance facility and improve shareholders...

SCNI - Scinai Reports Third Quarter 2023 Financial Results and Provides Business Update

JERUSALEM, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- Scinai Immunotherapeutics Ltd (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoi...
Previous 10 Next 10